These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 3086001)

  • 21. Control of Mycobacterium fortuitum and Mycobacterium intracellulare infections with respect to distinct granuloma formations in livers of BALB/c mice.
    Silva TR; Petersen AL; Santos Tde A; Almeida TF; Freitas LA; Veras PS
    Mem Inst Oswaldo Cruz; 2010 Aug; 105(5):642-8. PubMed ID: 20835610
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic control of resistance to Mycobacterium intracellulare infection in mice.
    Goto Y; Nakamura RM; Takahashi H; Tokunaga T
    Infect Immun; 1984 Oct; 46(1):135-40. PubMed ID: 6480104
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Establishment of Bcgr congenic mice and their susceptibility/resistance to mycobacterial infection.
    Xu DL; Goto Y; Amoako KK; Nagatomo T; Fujita T; Shinjo T
    Vet Microbiol; 1996 May; 50(1-2):73-9. PubMed ID: 8810009
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immune responsiveness in Mycobacterium avium-infected mice: changes in the proportion of T cell subsets and antibody production during the course of infection.
    Xu DL; Goto Y; Amoako KK; Nagatomo T; Uchida K; Shinjo T
    Clin Exp Immunol; 1995 Dec; 102(3):523-8. PubMed ID: 8536367
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the resistance of C57BL/6 and C3H/He mice to infection with Mycobacterium paratuberculosis.
    Veazey RS; Horohov DW; Krahenbuhl JL; Taylor HW; Oliver JL; Snider TG
    Vet Microbiol; 1995 Nov; 47(1-2):79-87. PubMed ID: 8604557
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Killing of Mycobacterium smegmatis by macrophages from genetically susceptible and resistant mice.
    Denis M; Forget A; Pelletier M; Gervais F; Skamene E
    J Leukoc Biol; 1990 Jan; 47(1):25-30. PubMed ID: 2294152
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Growth of Mycobacterium tuberculosis in BCG-resistant and -susceptible mice: establishment of latency and reactivation.
    Brown DH; Miles BA; Zwilling BS
    Infect Immun; 1995 Jun; 63(6):2243-7. PubMed ID: 7768604
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetically regulated response to intravesical bacillus Calmette Guerin immunotherapy of orthotopic murine bladder tumor.
    Kadhim SA; Chin JL; Batislam E; Karlik SJ; Garcia B; Skamene E
    J Urol; 1997 Aug; 158(2):646-52. PubMed ID: 9224385
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of the Ity/Lsh/Bcg gene on the development of suppressor cell precursors in the early phase of the infection of mice with Mycobacterium lepraemurium.
    Gosselin D; Turcotte R; Lemieux S
    Clin Exp Immunol; 1994 May; 96(2):218-24. PubMed ID: 8187330
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of I-A expression by murine peritoneal macrophages: differences linked to the Bcg gene.
    Zwilling BS; Vespa L; Massie M
    J Immunol; 1987 Mar; 138(5):1372-6. PubMed ID: 3543128
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term persistence of BCG Pasteur in lungs of C57BL/6 mice following intranasal infection.
    Leversen NA; Sviland L; Wiker HG; Mustafa T
    Scand J Immunol; 2012 May; 75(5):489-99. PubMed ID: 22239126
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Strain differences in mouse cellular responses to Mycobacterium lepraemurium and BCG subcutaneous infections. I. Analysis of cell surface phenotype in local granulomas.
    Roch F; Bach MA
    Clin Exp Immunol; 1990 Jun; 80(3):332-8. PubMed ID: 2197047
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Bcg gene story.
    Skamene E
    Immunobiology; 1994 Oct; 191(4-5):451-60. PubMed ID: 7713559
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mycobacterium genavense infection in normal and immunodeficient mice.
    Matsiota-Bernard P; Vildé F; Nauciel C
    Microbes Infect; 2000 May; 2(6):575-80. PubMed ID: 10884607
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phenotypic expression of genetically-controlled natural resistance to Mycobacterium bovis (BCG).
    Stach JL; Gros P; Forget A; Skamene E
    J Immunol; 1984 Feb; 132(2):888-92. PubMed ID: 6361135
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Strain-specific differences in the genetic control of two closely related mycobacteria.
    Di Pietrantonio T; Hernandez C; Girard M; Verville A; Orlova M; Belley A; Behr MA; Loredo-Osti JC; Schurr E
    PLoS Pathog; 2010 Oct; 6(10):e1001169. PubMed ID: 21060820
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytokine-mediated activation of macrophages from Mycobacterium bovis BCG-resistant and -susceptible mice: differential effects of corticosterone on antimycobacterial activity and expression of the Bcg gene (Candidate Nramp).
    Brown DH; LaFuse W; Zwilling BS
    Infect Immun; 1995 Aug; 63(8):2983-8. PubMed ID: 7622220
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immune responsiveness in mice heavily infected with Mycobacterium kansasii.
    Hepper KP; Collins FM
    Immunology; 1984 Oct; 53(2):357-64. PubMed ID: 6490088
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of dose and route of inoculation and of mouse strain on the production of interleukin 2 in mice infected with Mycobacterium lepraemurium.
    Hoffenbach A; Lagrange PH; Bach MA
    Acta Leprol; 1984; 2(2-4):413-20. PubMed ID: 6398600
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Strain variation of lymphokine production and specific antibody secretion in mice infected with Mycobacterium lepraemurium.
    Hoffenbach A; Lagrange PH; Bach MA
    Cell Immunol; 1985 Mar; 91(1):1-11. PubMed ID: 3882240
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.